関連する実験動画
Updated: Jan 7, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.9K
甲状腺クリーゼによる呼吸不全に対する静脈-静脈体外式膜型人工肺(VV-ECMO)を用いた治療
Tatiana Getman1, Joseph Vu2, Hekmat Nasiri3
1Department of Internal Medicine, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA, USA.
The Permanente journal
|December 29, 2025
まとめ
甲状腺クリーゼは呼吸不全を引き起こす可能性がある。本症例報告では、重度の甲状腺クリーゼと呼吸不全を呈した患者に対し、静脈-静脈体外式膜型人工肺(VV-ECMO)が有効であったことを示す。
科学分野:
- 内分泌学
- クリティカルケア医学
- 心肺補助
背景:
- 甲状腺クリーゼは死亡率の高い重篤な内分泌学的緊急症である。
- 呼吸器系の合併症は甲状腺クリーゼの重篤な合併症である。
- 静脈-動脈体外式膜型人工肺(VA-ECMO)は報告されているが、静脈-静脈体外式膜型人工肺(VV-ECMO)の使用はまれである。
研究 の 目的:
- VV-ECMOを必要とした重度の甲状腺クリーゼのまれな症例を報告する。
- この重篤な病態における管理戦略と体外循環サポートの役割について論じる。
- 甲状腺クリーゼにおけるVV-ECMOによる患者の転帰を強調する。
主な方法:
- 未治療の高血圧を呈した41歳女性の甲状腺クリーゼの症例報告。
- 甲状腺クリーゼに対する薬物療法とVV-ECMOによる呼吸補助を含む管理。
- 臨床経過、管理上の意思決定、転帰の分析。
主要な成果:
- 患者は甲状腺クリーゼと重度の呼吸不全で来院した。
- 呼吸補助のためにVV-ECMOが導入された。
- 患者の状態は安定化し、転帰が評価された。
結論:
- VV-ECMOは、重度の甲状腺クリーゼにおける呼吸補助の実行可能な選択肢となりうる。
- 効果的な管理には、集学的アプローチが必要である。
- 体外循環サポートは、生命を脅かす甲状腺クリーゼと呼吸不全の患者の転帰を改善する可能性がある。
関連する概念動画
Acute Respiratory Failure-V
413
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
413
Acute Respiratory Failure-III
722
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
722
Acute Respiratory Failure-IV
488
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
488
Acute Respiratory Failure-II
980
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
980
Acute Respiratory Failure-I
784
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
784
Endotracheal Tube Extubation
3.4K
Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
3.4K

